Advanced Squamous Non-Small Cell Lung Carcinoma
4 clinical trials · Condition
◉ Watch Advanced Squamous Non-Small Cell Lung Carcinoma
| Record | Firm | Date |
|---|---|---|
| Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer (NCT06463665) | Genelux Corporation | 2024-09-26 |
| TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. (NCT05718167) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-02-01 |
| RBN-2397 in Combination With Pembrolizumab in Patients With SCCL (NCT05127590) | Ribon Therapeutics, Inc. | 2022-03-15 |
| CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer (NCT02955290) | Roswell Park Cancer Institute | 2016-12-22 |
Track Advanced Squamous Non-Small Cell Lung Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.